One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Social Media and Sports Cardiology: Potential Pitfalls and the Importance of Informed Communication.
Kim, Jonathan H. MD, MSc; Martinez, Matthew W. MD; Ackerman, Michael J. MD, PhD
doi : 10.1161/CIRCULATIONAHA.123.064082
Volume 147(19) pgs. 1419-1487 May 09, 2023
Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial.
Verma, Atul MD; Haines, David E. MD; Boersma, Lucas V. MD; Sood, Nitesh MD; Natale, Andrea MD; Marchlinski, Francis E. MD; Calkins, Hugh MD; Sanders, Prashanthan MBBS; Packer, Douglas L. MD; Kuck, Karl-Heinz MD; Hindricks, Gerhard MD; Onal, Birce PhD; Cerkvenik, Jeffrey MS; Tada, Hiroshi MD; DeLurgio, David B. MD; on behalf of the PULSED AF Investigators
doi : 10.1161/CIRCULATIONAHA.123.063988
Pulsed field ablation uses electrical pulses to cause nonthermal irreversible electroporation and induce cardiac cell death. Pulsed field ablation may have effectiveness comparable to traditional catheter ablation while preventing thermally mediated complications.
Pulsed Field Ablation: Is It Better Than Conventional Thermal Ablation for Treatment of Atrial Fibrillation?.
Russo, Andrea M. MD
Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study.
Perez de Isla, Leopoldo PhD; Diaz-Diaz, Jose L. PhD; Romero, Manuel J. PhD; Muniz-Grijalvo, Ovidio PhD; Mediavilla, Juan D. PhD; Argueso, Rosa PhD; Sanchez Munoz-Torrero, Juan F. PhD; Rubio, Patricia PhD; Alvarez-Banos, Pilar PhD; Ponte, Paola PhD; Manas, Dolores PhD; Suarez Gutierrez, Lorena PhD; Cepeda, Jose Maria PhD; Casanas, Marta PhD; Fuentes, Francisco PhD; Guijarro, Carlos PhD; Angel Barba, Miguel PhD; Saltijeral Cerezo, Adriana PhD; Padro, Teresa PhD; Mata, Pedro PhD; on behalf of the SAFEHEART Study Group
doi : 10.1161/CIRCULATIONAHA.122.062557
The effect of alirocumab, a PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor, on coronary plaque burden in patients with familial hypercholesterolemia has not been addressed.
Alox15/15-HpETE Aggravates Myocardial Ischemia-Reperfusion Injury by Promoting Cardiomyocyte Ferroptosis.
Cai, Wenbin PhD; Liu, Le PhD; Shi, Xuelian MS; Liu, Yanan PhD; Wang, Jin PhD; Fang, Xuan PhD; Chen, Zhipeng PhD; Ai, Ding PhD; Zhu, Yi MD; Zhang, Xu PhD
doi : 10.1161/CIRCULATIONAHA.122.060257
Myocardial ischemia-reperfusion (I/R) injury causes cardiac dysfunction to myocardial cell loss and fibrosis. Prevention of cell death is important to protect cardiac function after I/R injury.
A Tale of Two Parallel Rhythms.
Gupta, Anshul R. MD, MS; Deshmukh, Abhishek J. MBBS; Del-Carpio Munoz, Freddy MD, MS
Cardioprotection by Peroxidase Activity of Prostaglandin H Synthases in Ischemia/Reperfusion Injury.
Liu, Guizhu PhD ,,,*; Liu, Qian PhD ,*; Wan, Naifu MD; Shen, Xia PhD; Cui, Hui PhD; Dong, Cheng PhD; Zhang, Xu PhD; Yin, Huiyong PhD; Wang, Jian MD, PhD; Funk, Colin D. PhD; Yu, Ying MD, PhD
Cardiovascular Disease Risk Factors in Women: The Impact of Race and Ethnicity: A Scientific Statement From the American Heart Association.
Mehta, Laxmi S. MD, FAHA, Chair; Velarde, Gladys P. MD, FAHA; Lewey, Jennifer MD, MPH; Sharma, Garima MD; Bond, Rachel M. MD; Navas-Acien, Ana MD, PhD; Fretts, Amanda M. MPH, PhD; Magwood, Gayenell S. PhD, RN, FAHA; Yang, Eugene MD; Blumenthal, Roger S. MD, FAHA; Brown, Rachel-Maria MD; Mieres, Jennifer H. MD, FAHA, Vice Chair; on behalf of the American Heart Association Cardiovascular Disease and Stroke in Women and Underrepresented Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Hypertension; Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Lifestyle and Cardiometabolic Health; Council on Peripheral Vascular Disease; and Stroke Council
doi : 10.1161/CIR.0000000000001139
AB Cardiovascular disease is the leading cause of death in women, yet differences exist among certain racial and ethnic groups. Aside from traditional risk factors, behavioral and environmental factors and social determinants of health affect cardiovascular health and risk in women.
